Jean-Marie Vigouret

Title: The Innovative Contributions of Jean-Marie Vigouret

Introduction

Jean-Marie Vigouret is a notable inventor based in Alle, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of conditions associated with cerebral ischaemia and alcohol abuse. With a total of three patents to his name, Vigouret's work has the potential to impact many lives.

Latest Patents

Vigouret's latest patents include the use of naphthoxazines for the treatment of conditions associated with cerebral ischaemia, such as stroke. This innovative approach involves compounds of formula I, wherein R1, R2, R3, and R4 are defined in the description. Additionally, he has developed dibenz(CD,F)indoles, specifically 4,5,5a,6-tetrahydro-dibenz[cd,f]indole derivatives. These derivatives, which contain at least one oxy substituent in one or both of the fused benzene rings, are aimed at preventing alcohol abuse.

Career Highlights

Vigouret is currently associated with Sandoz GmbH, a prominent company in the pharmaceutical industry. His work at Sandoz has allowed him to focus on innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Vigouret has collaborated with esteemed colleagues such as Joachim Nozulak and Andre Sauter. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Jean-Marie Vigouret's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to pave the way for advancements in treatment options for serious medical conditions.